The use of surfactants in 2009

Area of Science:

• Neonatal Medicine
• Pulmonology
• Biochemistry

Background:

• Surfactant replacement therapy has significantly advanced neonatal respiratory care since the 1980s.
• It is routinely recommended for respiratory distress syndrome (RDS) in preterm infants, alongside antenatal steroids.
• The optimal timing and use of surfactant therapy versus continuous positive airway pressure (CPAP) are under active investigation to reduce potential complications like bronchopulmonary dysplasia.

Purpose of the Study:

• To review the current status and evolving applications of surfactant replacement therapy in neonatal care.
• To explore the balance between surfactant administration and non-invasive ventilation strategies like CPAP for RDS.
• To examine the use of surfactants in non-RDS conditions and novel applications, such as drug delivery.

Main Methods:

• Review of existing literature on surfactant replacement therapy and its clinical applications.
• Analysis of recent studies investigating optimal treatment strategies for neonatal respiratory distress.
• Exploration of emerging uses of surfactants in neonatal medicine.

Main Results:

• Surfactant therapy, combined with antenatal steroids, enhances survival rates for preterm infants with RDS.
• There is ongoing research to optimize the use of surfactant and CPAP to minimize the need for mechanical ventilation and associated risks.
• Evidence for surfactant use in conditions beyond RDS is less robust, but novel applications like targeted drug delivery show promise.

Conclusions:

• Surfactant replacement therapy remains a cornerstone in managing neonatal respiratory distress syndrome.
• Further research is crucial to refine treatment protocols, balancing surfactant administration with non-invasive support to improve outcomes and reduce complications.
• Development of synthetic surfactants and exploration of new delivery methods represent future directions in the field.